SLC16A2, solute carrier family 16 member 2, 6567

N. diseases: 108; N. variants: 30
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE On the background of previously published patients we describe a proband initially considered as presenting with a severe PMD, whose diagnosis of AHDS due to a novel nonsense SLC16A2 mutation unraveled two previously undiagnosed generations of affected males who died in infancy from unexplained reasons. 27234264 2016
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE We describe a novel MCT8 mutation (S290F) in 4 generations of a family with Allan-Herndon-Dudley Syndrome. 26426690 2015
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease UNIPROT Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations. 25527620 2015
Allan-Herndon-Dudley syndrome (AHDS)
1.000 Biomarker disease BEFREE A three-and-a-half-year-old male with clinical and biochemical AHDS phenotype and a history of normal neonatal screening for hypothyroidism underwent SLC16A2 molecular analysis. 25517855 2015
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease UNIPROT We describe a novel MCT8 mutation (S290F) in 4 generations of a family with Allan-Herndon-Dudley Syndrome. 26426690 2015
Allan-Herndon-Dudley syndrome (AHDS)
1.000 Biomarker disease BEFREE As SLC16A2 encodes the monocarboxylate transporter 8 (MCT8), a thyroid hormone transporter, patients with Allan-Herndon-Dudley syndrome present a specific altered thyroid hormone profile. 25380603 2015
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease CLINVAR Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations. 25527620 2015
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE MCT8 mutations cause an X-linked syndromic disorder known as Allan-Herndon-Dudley syndrome (AHDS) that is characterized by severe psychomotor delays, abnormal thyroid function, and hypomyelinated leukodystrophies. 25896225 2015
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease UNIPROT We report a patient with Allan-Herndon-Dudley syndrome characterized by developmental delay, hypotonia, and delayed myelination caused by a novel SLC16A2 mutation (p.L291R). 25380603 2015
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Mutations in MCT8 are associated with the Allan-Herndon-Dudley syndrome (AHDS), characterized by severe psychomotor retardation and altered serum thyroid parameters. 25247785 2014
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Mutations in MCT8 result in the Allan-Herndon-Dudley syndrome, comprising severe psychomotor retardation and elevated serum T3 levels. 25389909 2014
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE The importance was better documented by the phenotype observed in patients harboring mutations of the monocarboxylate transporter 8 (MCT8) gene immediately linked to Allan-Herndon-Dudley syndrome, in which severe neurological findings are associated with abnormal TH levels. 25231447 2014
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease CLINVAR The role of Arg445 and Asp498 in the human thyroid hormone transporter MCT8. 24265446 2014
Allan-Herndon-Dudley syndrome (AHDS)
1.000 Biomarker disease GENOMICS_ENGLAND Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. 24847459 2014
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation. 25160547 2014
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease CLINVAR X-exome sequencing in Finnish families with intellectual disability--four novel mutations and two novel syndromic phenotypes. 24721225 2014
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Two mutations; one previously reported missense mutation (c.1111C > T), and one novel frameshift mutation (c. 990_991insGCTGC) were identified in SLC16A2, a gene that has been linked to Allan-Herndon-Dudley syndrome (AHDS). 24721225 2014
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Mutations in the TH transporter, monocarboxylate transporter 8 (MCT8), are associated with AHDS. 23161551 2013
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease UNIPROT To study the functional consequences of different MCT8 mutations in detail, we combined functional analysis in different cell types with live-cell imaging of the cellular distribution of seven mutations that we identified in patients with AHDS. 23550058 2013
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Mutations in the MCT8 gene coding for the monocarboxylate thyroid hormone transporter 8 have been associated with AHDS. 23419639 2013
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Mutations in the MCT8 gene are associated with Allan-Herndon-Dudley Syndrome (AHDS), consisting of severe psychomotor retardation and disturbed TH parameters. 23550058 2013
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Hemizygous MCT8 mutations in males cause severe psychomotor retardation, known as the Allan-Herndon-Dudley syndrome (AHDS), and abnormal serum TH levels. 23392090 2013
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE A partial deletion of the MCT8 gene (comprising five of six exons) was detected, confirming the suspected AHDS. 21896621 2011
Allan-Herndon-Dudley syndrome (AHDS)
1.000 GeneticVariation disease BEFREE Monocarboxylate transporter 8 (MCT8 or SLC16A2) mutations cause X-linked Allan-Herndon-Dudley syndrome. 21098685 2011
Allan-Herndon-Dudley syndrome (AHDS)
1.000 Biomarker disease CLINGEN Here we describe in detail the clinical and biochemical features in a boy affected by AHDS with severe neurological abnormalities and a novel de novo SLC16A2 gene insertion, 1343-1344insGCCC, resulting in a truncated protein lacking the last four transmembrane domains (TMDs) as well as the carboxyl cytoplasmic end. 20713192 2011